We are live on ! Find out more
RPID icon

Rapid Micro Biosystems
RPID

49 hedge funds and large institutions have $401M invested in Rapid Micro Biosystems in 2021 Q3 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

63.64% more ownership

Funds ownership: 0% → 63.64% (+64%)

Holders
49
Holders Change
+49
Holders Change %
–
% of All Funds
0.86%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
49
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$174M
2
DCP
D1 Capital Partners
New York
+$54.6M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$38.3M
4
JP Morgan Chase
JP Morgan Chase
New York
+$34.8M
5
BlackRock
BlackRock
New York
+$28.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$156M +$174M +8,434,560 New
DCP
2
D1 Capital Partners
New York
$48.8M +$54.6M +2,644,444 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$33.9M +$38.3M +1,856,042 New
JP Morgan Chase
4
JP Morgan Chase
New York
$31.1M +$34.8M +1,684,232 New
BlackRock
5
BlackRock
New York
$25.1M +$28.1M +1,360,027 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$20.8M +$23.3M +1,127,013 New
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$13.2M +$14.8M +716,666 New
AI
8
Advent International
Massachusetts
$10.7M +$11.9M +577,778 New
SAM
9
Sectoral Asset Management
Quebec, Canada
$9.44M +$10.6M +510,835 New
ABG
10
Ally Bridge Group
New York
$8.09M +$9.05M +437,960 New
PA
11
Perceptive Advisors
New York
$6.46M +$7.23M +350,000 New
PVI
12
Pura Vida Investments
New York
$6.13M +$6.86M +332,136 New
WP
13
Woodline Partners
California
$4.46M +$4.99M +241,457 New
CCM
14
CAAS Capital Management
New York
$4.43M +$4.95M +239,727 New
Goldman Sachs
15
Goldman Sachs
New York
$2.47M +$2.76M +133,513 New
FAM
16
Fred Alger Management
New York
$2.43M +$2.72M +131,505 New
Jennison Associates
17
Jennison Associates
New York
$2.28M +$2.55M +123,605 New
Wells Fargo
18
Wells Fargo
California
$1.84M +$2.06M +99,906 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.8M +$2.02M +97,756 New
State Street
20
State Street
Massachusetts
$1.69M +$1.89M +91,287 New
Northern Trust
21
Northern Trust
Illinois
$1.32M +$1.48M +71,436 New
Balyasny Asset Management
22
Balyasny Asset Management
Illinois
$1.16M +$1.3M +62,841 New
GCM
23
Ghisallo Capital Management
Massachusetts
$924K +$1.03M +50,000 New
TD Asset Management
24
TD Asset Management
Ontario, Canada
$892K +$998K +48,316 New
TGHSA
25
TPG Group Holdings (SBS) Advisors
Texas
$885K +$990K +47,935 New
1
2

RPID Hedge Fund Activity: Q3 2021 in Review

49 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q3 2021, worth a combined $401M.

Buyers outnumbered sellers: 49 funds opened new RPID positions and 0 closed out — a net gain of 49 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bain Capital Life Sciences Investors, opening a new position worth an estimated $174M.

  • 49 institutional investors held Rapid Micro Biosystems (RPID) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $401M of Rapid Micro Biosystems stock for Q3 2021.
  • 49 funds opened new Rapid Micro Biosystems positions in Q3 2021 and 0 closed out, a net change of +49 holders.
  • The largest Rapid Micro Biosystems buyer in Q3 2021 was Bain Capital Life Sciences Investors, an estimated $174M added.

Based on aggregated 13F filings for Q3 2021.